Sygnature Discovery


Sygnature Discovery logo

Sygnature Discovery is a leading independent integrated drug discovery and pre-clinical services CRO. Founded in 2004 and private equity-backed since 2017, we operate a fully-enabled research facility in Nottingham, UK, housing nearly 400 staff (80% of our scientists have PhDs). Our experienced R&D scientists possess all the professional skills and know-how required to undertake the most demanding of drug discovery and/or pre-clinical development projects and drive them from target validation, through hit identification, hit-to-lead and lead optimization to development candidate. Sygnature collaborates with its partners via risk share and FTE-based collaborations.

Contact Sygnature Discovery via their website


News Archive

09/10/2020   Sygnature Discovery wins Medilink Outstanding Achievement Award...more
24/09/2020   Sygnature Discovery expands DMPK capabilities with XenoGesis acquisition...more
09/09/2020   Sygnature Discovery appoints Dr Andy Mead at RenaSci...more
23/06/2020   Sygnature Discovery boosts senior management team welcoming Dr Paul Overton...more
11/06/2020   Sygnature assists New York Medical College in Covid-19 fight...more
03/06/2020   Sygnature expands capabilities with acquisition of Alderley Oncology...more
29/05/2020   Sygnature Discovery expands SPR capacity...more
22/05/2020   Sygnature Group adds pharmacology expertise to BD team...more
01/04/2020   Sygnature Discovery Reports Key Appointments and Retirements at RenaSci...more
15/01/2020   Sygnature Discovery strengthens DMPK team...more

09/12/2019   Sygnature Discovery wins Outstanding Achievement Award...more
04/11/2019   Sygnature Discovery invests in high-throughput screening capability...more
12/09/2019   Sygnature Discovery moves US base to Kendall Square...more
09/08/2019   Sygnature Discovery raises over £2,776 for Cancer Research UK...more
06/08/2019   Sygnature Discovery named Finalist in OBN Award for Best CRO...more
29/05/2019   Sygnature Discovery and RenaSci strengthen service-offering...more
28/05/2019   Sygnature Discovery test drive SPR-M...more
17/04/2019   Sygnature Discovery announces collaboration with software firm SilcsBio...more
21/03/2019   Senior appointments enhance Sygnature Discovery's DMPK capabilities...more
12/03/2019   Sygnature creates ScanStation for efficient internal lab management...more

14/08/2018   Sygnature Discovery Establishes Us Office...more
14/08/2018   Sygnature Discovery announces ambitious expansion plans...more
03/08/2018   Sygnature Discovery gains cyber security certification...more
23/07/2018   Sygnature Discovery raises over £2,700 for Parkinson's UK...more
01/07/2018   Sygnature Discovery has appointed Andy Lindstrom as Director of Marketing...more
01/06/2018   Sygnature Discovery appoints Dr Bill Marathias as VP of Business Development for USA...more
26/02/2018   Discovery Building, Sygnature Discovery's HQ, nominated for RICS Awards...more
07/02/2018   Sygnature Discovery to co-host Predictive Toxicology in Discovery DMPK conference...more

19/12/2017   Sygnature Discovery featured on BBC News as a UK life science success...more
09/10/2017   Phoenix Equity Partners announces investment in Sygnature Discovery...more
02/10/2017   Sygnature Discovery forms a strategic alliance with ApconiX...more
27/07/2017   Sygnature Discovery named as Best CRO Finalist in OBN Awards 2017...more
25/07/2017   Sygnature Discovery presented with Queen’s Award for Enterprise 2017...more
28/06/2017   Sygnature Discovery's new HQ is officially open...more
01/06/2017   SelectScience Editorial Article: Insights into Sygnature Discovery...more
16/05/2017   Sygnature Discovery one of London Stock Exchange’s 1000 Companies to Inspire Britain...more
02/05/2017   Sygnature Discovery enhances Biophysics capability...more
21/04/2017   Sygnature Discovery receives a prestigious Queen’s Award for Enterprise...more
07/04/2017   Sygnature Discovery ranked in the Financial Times FT1000f fastest growing companies list...more
30/03/2017   Double celebration for TopiVert and Sygnature Discovery...more
13/03/2017   Sygnature Discovery announces collaboration with Keapstone Therapeutics...more
24/02/2017   Sygnature Discovery in Sunday Times Lloyds SME Export Track 100 for intl. client base...more
01/02/2017   Sygnature Discovery, Mironid, and Peak Proteins to collaborate...more
17/01/2017   Sygnature Discovery announce collaboration with Pelago Bioscience...more

12/10/2016   Sygnature Discovery appoints Ed Browne as Associate Director of DMPK...more
05/10/2016   Sygnature Discovery and Viramatix Announce Anti-Viral Drug Discovery Strategic Alliance...more
21/07/2016   Sygnature Discovery Acquires BMG LABTECH PHERAstar® FSX...more
15/07/2016   Sygnature Discovery Set For Further Growth With Grant From N2 Business Growth Fund...more
04/07/2016   Sygnature Discovery Acquired ImageXpress® Micro Confocal Imaging System...more
16/06/2016   Sygnature Discovery's CEO Wins RSC’s Entrepreneur of the Year Award 2016...more
23/05/2016   Caldan Therapeutics collaborates with Sygnature Discovery...more
15/05/2016   Sygnature Makes Sunday Times Heathrow SME Export Track 100...more
12/05/2016   Caldan Therapeutics Announces Drug Discovery Collaboration with Sygnature Discovery...more
29/04/2016   Topping-out Ceremony for Sygnature's New Discovery Building...more
04/03/2016   Sygnature Discovery to Host Kinase 2016 Event in Nottingham...more
16/02/2016   Sygnature Discovery & RenaSci announce strategic alliance...more
03/02/2016   Sygnature Discovery has delivered 21k+ compounds to European Lead Factory (ELF)...more
30/01/2016   Sygnature Discovery starts 2016 with two key appointments...more
25/01/2016   Sygnature Discovery's group invests in new start up, Peak Proteins...more
10/01/2016   Drug Discovery Today details ELF consortium study featuring Sygnature Discovery...more

08/11/2015   Sygnature will host SCI's 'Young Chemist in Industry'symposium...more
07/10/2015   Ground breaking news for Sygnature Discovery...more
30/07/2015   Sygnature Discovery delivers clinical candidate to Corcept Therapeutics...more
28/07/2015   Sygnature Discovery and Essen BioScience form Strategic Alliance...more
18/05/2015   Sygnature's export growth recognised in national league table...more
07/04/2015   Sygnature Discovery receives French Research accreditation...more
01/02/2015   Sygnature Discovery strengthens team with three key appointments...more

07/12/2014   Sygnature Discovery Welcomes New Associate Director of Bioscience ...more
25/11/2014   Sygnature Discovery Case Study in Creative Quarter publication...more
19/10/2014   Sygnature Discovery Speaker Summaries published from Aspects of Modern Drug Discovery...more
07/10/2014   Sygnature Celebrates 10 Years of Drug Discovery...more
24/04/2014   New Business Development Director at Sygnature Discovery...more

17/10/2013   Sygnature Discovery and Proteros Biostructures Establish Strategic Alliance...more
14/10/2013   Sygnature Discovery wins Business of the Year Award 2013...more
30/09/2013   Sygnature Discovery appoints new Non-Executive Director...more
23/09/2013   Regional Business Award Success for Sygnature Discovery...more
09/09/2013   Sygnature Discovery selected by CellCentric for prostate cancer programme...more
22/08/2013   Sygnature Discovery finalist in Nottinghamshire’s Best Business Awards...more
24/05/2013   Sygnature Discovery wins Nottingham Post Excellence in Science and Technology Award...more
22/04/2013   Sygnature Discovery provided medicinal chemistry support to new CoCo Therapeutics...more
18/04/2013   Sygnature Discovery selected as Business Awards 2013 finalist ...more
21/03/2013   Sygnature Discovery featured on BBC Radio 4‘s "Today" programme...more
07/02/2013   Sygnature Discovery SME Partner in €196 Million European Lead Factory ...more

30/11/2012   Sygnature Discovery Appoints VP, Business Development North America...more
09/10/2012   BerGenBio selects Sygnature Discovery for BGB002 drug development...more
02/10/2012   The Federated CRO Model: delivering Drug Discovery Expertise...more
15/05/2012   Sygnature Discovery and Pneumolabs Establish Strategic Alliance...more
01/03/2012   National Retrosynthesis Competition ­Sygnature´s Medicinal Chemists are Runners-Up...more
23/01/2012   Sygnature Chemists reach Final in Retrosynthesis Competition ...more
09/01/2012   Sygnature Discovery Nearsourcing article...more

16/12/2011   Sygnature Discovery and Cyprotex Extend Successful Alliance for a Further Two Years ...more
12/12/2011   BioScience Group at Sygnature Discovery is recruiting!...more
05/12/2011   Sygnature Discovery moves into Laboratory #3 ...more
21/11/2011   BBC News Features Sygnature Discovery ...more
31/10/2011   Sygnature Discovery and Saretius Establish Strategic Alliance ...more
06/09/2011   Sygnature Chemical Services becomes Sygnature Discovery...more
08/07/2011   Entrepreneur of the Year Award Winner­ Simon Hirst...more
09/05/2011   Sygnature Founder Simon Hirst finalist in Nottingham Post Entrepreneur Award ...more